If you need more lookups,
subscriptions start at $34 USD/month.
Ingmar Bruns Location
Cambridge, MA, US
Ingmar Bruns Work
Chief Medical Officer @ (January 2024 - Present)
Member Board of Directors @ (January 2025 - Present)
TA Head, Hematologic Malignancies, Oncology Research and Development @ (January 2022 - December 2024)
Senior VP Global Product Development Oncology @ (January 2021 - December 2022)
Executive Vice President and Chief Medical Officer @ (November 2020 - December 2021)
Senior Vice President and Head of Clinical Development @ (January 2020 - October 2020)
Vice President of Clinical Development @ (July 2017 - January 2020)
Clinical Development Physician Leader and US site representative, Clinical Development @ (May 2013 - July 2017)
Adjunct Physician-Scientist @ (September 2010 - December 2016)
Attending Physician @ (July 2010 - July 2013)
Fellow Internal Medine, Hematology and Oncology @ (November 2003 - July 2010)
Ingmar Bruns Education
Albert Einstein College of Medicine
Medical University of Vienna
(Medicine)
Stellenbosch University
Medicine (Medicine)
Universität zu Lübeck
Doctor of Medicine - MD (Medicine)
Ingmar Bruns Skills
Molecular Biology
Microsoft Office
Onkologie
Project Management
Medicine
Molekularbiologie
Bone Marrow
Oncology
Clinical Research
Microsoft Excel
Haematologie
Klinische Entwicklung
Biomarkers
Pharmaforschung
Zellbiologie
Klinische Studien
Strategic Planning
Immunologie
Management
Healthcare Management
Science
Hospitals
Microsoft Word
Ingmar Bruns Summary
Ingmar Bruns, based in Cambridge, MA, US, is currently a Chief Medical Officer at Zentalis Pharmaceuticals. Ingmar Bruns brings experience from previous roles at Radiant Biotherapeutics, Pfizer and Trillium Therapeutics Inc.. Ingmar Bruns holds a Albert Einstein College of Medicine. With a robust skill set that includes Molecular Biology, Microsoft Office, Onkologie, Project Management, Medicine and more. Ingmar Bruns has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ingmar Bruns?
Find contact details for 700 million professionals.